We are live on ! Find out more
RCUS icon

Arcus Biosciences
RCUS

67 hedge funds and large institutions have $290M invested in Arcus Biosciences in 2018 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 27 increasing their positions, 13 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

108% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 13

100% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 10

25% more funds holding in top 10

Funds holding in top 10: 4 → 5 (+1)

18% more funds holding

Funds holding: 57 → 67 (+10)

10.09% more ownership

Funds ownership: 50.47% → 60.56% (+10%)

7% less capital invested

Capital invested by funds: $313M → $290M (-$22.9M)

Holders
67
Holders Change
+10
Holders Change %
+17.54%
% of All Funds
1.49%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.11%
New
20
Increased
27
Reduced
13
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
BI
BVF Inc
California
+$15.8M
2
BlackRock
BlackRock
New York
+$15M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$7.73M
4
State Street
State Street
Massachusetts
+$4.91M
5
Northern Trust
Northern Trust
Illinois
+$2.32M

Top Sellers

1
FCMI
Foresite Capital Management III
California
-$16.5M
2
EC
EcoR1 Capital
California
-$11.8M
3
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University
California
-$6.26M
4
PHS
PFM Health Sciences
California
-$5.87M
5
HIM
Hillhouse Investment Management
Cayman Islands
-$4.96M
Name Holding Trade Value Shares
Change 		Change in
Stake
Morgan Stanley
26
Morgan Stanley
New York
$549K +$411K +35,192 +224%
Wells Fargo
27
Wells Fargo
California
$542K +$469K +40,165 +395%
MML Investors Services
28
MML Investors Services
Massachusetts
$535K -$22.9K -1,962 -4%
California State Teachers Retirement System (CalSTRS)
29
California State Teachers Retirement System (CalSTRS)
California
$529K +$410K +35,090 +250%
Swiss National Bank
30
Swiss National Bank
Switzerland
$465K +$504K +43,200 New
Deutsche Bank
31
Deutsche Bank
Germany
$439K +$233K +19,919 +95%
Goldman Sachs
32
Goldman Sachs
New York
$432K +$255K +21,863 +120%
RhumbLine Advisers
33
RhumbLine Advisers
Massachusetts
$429K +$465K +39,842 New
OAM
34
Oxford Asset Management
United Kingdom
$356K +$386K +33,025 New
American Century Companies
35
American Century Companies
Missouri
$352K +$382K +32,717 New
Jane Street
36
Jane Street
New York
$323K +$350K +29,957 New
B
37
Bailard
California
$269K +$292K +25,000 New
Marshall Wace
38
Marshall Wace
United Kingdom
$249K +$62.4K +5,342 +30%
Bank of America
39
Bank of America
North Carolina
$225K +$213K +18,240 +709%
TD Asset Management
40
TD Asset Management
Ontario, Canada
$224K -$23.4K -2,003 -9%
AIG
41
American International Group
New York
$223K +$169K +14,503 +235%
LFM
42
Lumina Fund Management
New York
$214K – – –
WPIC
43
White Pine Investment Company
Michigan
$204K +$221K +18,939 New
MIM
44
MetLife Investment Management
New Jersey
$168K +$183K +15,645 New
UBS Group
45
UBS Group
Switzerland
$145K +$131K +11,187 +491%
CS
46
Credit Suisse
Switzerland
$143K +$154K +13,229 New
VOYA Investment Management
47
VOYA Investment Management
Georgia
$139K +$151K +12,952 New
MLICM
48
Metropolitan Life Insurance Company (MetLife)
New York
$123K +$134K +11,459 New
Citigroup
49
Citigroup
New York
$122K +$68K +5,824 +105%
California Public Employees Retirement System
50
California Public Employees Retirement System
California
$118K – – –
1
2
3 4

RCUS Hedge Fund Activity: Q4 2018 in Review

67 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Arcus Biosciences (RCUS) for Q4 2018, worth a combined $290M — down 7.3% from $313M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new RCUS positions and 10 closed out — a net gain of 10 holders — while 27 added to existing stakes and 13 trimmed.

The largest buyer was BVF Inc, adding an estimated $15.8M. The largest seller was Foresite Capital Management III, cutting an estimated $16.5M.

  • 67 institutional investors held Arcus Biosciences (RCUS) as of Q4 2018, up from 57 in Q3 2018.
  • Funds reported $290M of Arcus Biosciences stock for Q4 2018, down 7.3% quarter-over-quarter.
  • 20 funds opened new Arcus Biosciences positions in Q4 2018 and 10 closed out, a net change of +10 holders.
  • The largest Arcus Biosciences buyer in Q4 2018 was BVF Inc, an estimated $15.8M added.
  • The largest Arcus Biosciences seller in Q4 2018 was Foresite Capital Management III, an estimated $16.5M sold.

Based on aggregated 13F filings for Q4 2018.